Emerging Company TRANSACTIONAL

Getting a startup off the ground? Learn how we can help at WilmerHaleLaunch.com.


WilmerHale’s Emerging Company Practice has helped thousands of entrepreneurs successfully launch their businesses; raise billions in angel, venture and strategic financing; and take their companies to sale, IPO and market leadership.

Our more than 100 dedicated corporate lawyers are stationed in some of the most active startup markets, including Silicon Valley, Boston, New York, Berlin, Frankfurt and London. We have a longstanding tradition of representing emerging companies and entrepreneurs across a wide range of industries, and offer strategic advice and an indispensable business perspective that is critical to our clients’ success. Our team-oriented approach to service gives clients the flexibility to call on a number of experienced lawyers at any time, and our innovative QuickStart Program enables us to provide the highest level of responsiveness in a cost-effective manner. Additionally, we are able to draw on the full spectrum of renowned services offered by the firm—from intellectual property and labor and employment to tax, litigation, regulatory issues and beyond. We are extraordinarily proud of the innovative clients we serve, many of whom have helped change the way we all work, think and live.

Contacts

Sort By
Buckland, Peter

Peter Buckland

Vice Chair, Corporate Practice Group

Co-Chair, Emerging Company Practice

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Gammell, David

David D. Gammell

Co-Chair, Emerging Company Practice

+1 617 526 6839 (t)

david.gammell@wilmerhale.com

Bain, Mick

Mick Bain

Partner

+1 617 526 6158 (t)

michael.bain@wilmerhale.com

Boot, Jeannette K.

Jeannette K. Boot

Partner

+1 212 295 6507 (t)

jeannette.boot@wilmerhale.com

Borden, Mark G.

Mark G. Borden

Partner

+1 617 526 6675 (t)

mark.borden@wilmerhale.com

Bothwick, Jay E.

Jay E. Bothwick

Partner

+1 617 526 6526 (t)

jay.bothwick@wilmerhale.com

Braun, Martin

Dr. Martin Braun

Partner

+49 69 27 10 78 207 (t)

martin.braun@wilmerhale.com

Brown, Lillian

Lillian Brown

Partner

+1 202 663 6743 (t)

lillian.brown@wilmerhale.com

Buckland, Peter

Peter Buckland

Partner

+1 650 858 6036 (t)

peter.buckland@wilmerhale.com

Coates, Sam

Samuel S. Coates

Partner

+1 650 858 6000 (t)

samuel.coates@wilmerhale.com

Experience

We work with founders to properly set up their companies; review business plans and identify companies’ key strengths and weaknesses before approaching financing sources; license core technology; develop strategies to obtain funding and negotiate terms for initial and later-stage financings; prepare and implement key agreements with management, employees, consultants and advisors; design equity incentive plans; and advise clients on how best to achieve liquidity. We also attend board meetings and offer strategic advice and counseling on important business decisions, as well as guidance on forming and running an effective board of directors.

Our lawyers represent life sciences companies—including those in the biotechnology, medical device and healthcare sectors—as well as technology companies in a broad range of industries, including consumer Internet, cybersecurity, digital media, mobile technology, robotics, software, hardware, big data, and clean technology. In addition to our corporate experience, we are able to tap into the deep technical and scientific knowledge of our attorneys who hold degrees in fields such as biochemistry, biology, biomedical engineering, chemical engineering, chemistry, computer science, electrical engineering, genetics, immunology, information systems, mathematics, mechanical engineering, medicine, microbiology, organic chemistry and systems engineering. As a result, we have a sophisticated understanding of the important technical and intellectual property issues facing companies in these sectors.

Venture capital deals are a cornerstone of our practice, and reflect our longstanding focus on emerging technology and life sciences companies. In 2014, we served as counsel in more than 300 venture financings raising in excess of $8 billion, including some of the largest and most prominent deals of the year. Since 2004, we have handled more than 2,750 venture financings raising approximately $30 billion. Learn more about our venture capital capabilities.

Publications & News

View

July 1, 2015

WilmerHale Named a Leading National Firm in the United States by The Legal 500

The Legal 500 United States has released its annual rankings, selecting WilmerHale as one of the preeminent law firms in the country.

May 22, 2015

Federal Trade Commission Signals Intensified Focus on Security-By-Design and the Internet of Things With New Start with Security Initiative for Small and Medium-Sized Businesses

While the FTC's initial focus in the Start with Security initiative has been on providing guidance to small and medium-sized businesses, it also serves to put companies of all sizes on notice that the FTC will be increasingly targeting security practices relating to emerging technologies, apps, connected household devices and the "Internet of Things."

May 19, 2015

WilmerHale Practices, Lawyers Ranked Among Nation’s Best by Chambers USA

Chambers USA: America's Leading Lawyers for Business announced its final rankings for the 2015 edition, with WilmerHale ranking among the nation's best in 46 practice area categories. Chambers also ranked 86 WilmerHale attorneys as leaders in their respective fields.

May 6, 2015

Selected 2015 Technology Transactions

For more than four decades, we have represented technology clients in venture capital financings, public offerings, and mergers and acquisitions; handled their licensing, outsourcing, services, joint venture, development and distribution transactions throughout the world; protected their innovations through patent prosecution and portfolio development; defended their interests in enterprise-critical patent litigation; and navigated regulatory issues vital to their success.

May 6, 2015

Selected 2015 Life Sciences Transactions

Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

May 1, 2015

SEC Adopts Rules to Implement Regulation A+, Providing New Avenue for Capital Formation

On March 25, 2015, the Securities and Exchange Commission adopted amendments to Regulation A pursuant to Section 401 of the Jumpstart Our Business Startups Act for offers and sales of up to $50 million of securities annually. Regulation A+ creates two tiers of offerings that are exempt from registration under the Securities Act of 1933.

April 24, 2015

FTC Finalizes First Privacy Settlement Against a Retail Tracking Firm

In a first-of-its-kind enforcement action, the Federal Trade Commission on Thursday voted along party lines to settle deception allegations against Nomi Technologies, a company whose technology allows retailers to track the movement of customers within stores.

April 16, 2015

WilmerHale Expands Life Sciences and Emerging Company Practices in Silicon Valley with New Partner

WilmerHale is pleased to welcome Samuel Coates as a partner in the Palo Alto office. Mr. Coates joins the firm as a member of the Corporate, Emerging Company and Life Sciences Practice Groups.

April 10, 2015

Tax Time Alert: Key Things to Know About Founders Preferred Stock

An article by John Demeter published to Xconomy on April 10, 2015.

April 8, 2015

Silicon Valley Robot Block Party Draws Enthusiastic Crowds to WilmerHale

Crowds of investors, fans and students celebrated the region's thriving robotics industry and its many innovators at the 2015 Silicon Valley Robot Block Party hosted by WilmerHale and Silicon Valley Robotics.

2015 Reports

WilmerHale's annual IPO, Venture Capital and M&A Reports offer insights into market conditions and provide comprehensive statistics and analysis that are hard to find elsewhere.

Our  2015 IPO Report offers a detailed analysis of, and outlook for, the IPO market. The report features regional breakdowns, useful IPO market metrics, an update on the rates of adoption of various elements of JOBS Act relief available to emerging growth companies, and helpful tips on how to keep your directed share program company-friendly. We examine the pros and cons of employee stock purchase plans; review various SEC, stock exchange and other considerations around director independence; address key areas of regulatory diligence for companies going public; and offer a helpful walk-through of the process of SEC review of Form S-1 registration statements in the lead-up to an IPO.

The  2015 Venture Capital Report offers an in-depth analysis of, and outlook for, the US and European venture capital markets. The report features industry and regional breakdowns; an analysis of trends in venture capital financing, convertible debt and VC-backed company M&A deal terms; and a look at important considerations for startup founders weighing the costs, benefits and optimal timing for company incorporation.

Our  2015 M&A Report contains a detailed review of, and outlook for, the global M&A market. Other highlights include a comparison of deal terms in public and private acquisitions, updates on takeover defenses and the current climate around proxy access, and a look at the use of social media by public companies and activist shareholders in contested situations. We also examine recent trends in merger control, discuss lessons from Cigna v. Audax for sales of VC-backed companies structured as mergers, address the challenges posed by pre-IPO acquisitions, and survey key terms in sales of VC-backed companies.

Each report also includes a center spread showcasing prominent recent transactions in each area and company counsel rankings from independent sources showing WilmerHale's preeminence as counsel in IPOs, VC financings and sales of VC-backed companies.

To request a hard copy of any of the reports, contact the WilmerHale Client Development Department at ClientDevelopment@wilmerhale.com or call +1 617 526 5600.

 

QuickStart Program

Our QuickStart Program has been recognized by Financial Times for its innovative approach to working with startups and other emerging companies. For those companies that qualify, the QuickStart Program has two parts: one focuses on giving startups the critical guidance and legal advice they need to get off the ground and gain a competitive advantage, without the need to worry about cost; the other enables startups to continue to get the advice they need as they begin to grow their businesses, while helping them manage their cash. Contact us to learn more.